Hilltop Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-957
Closed -$309K 923
2025
Q3
$309K Buy
+957
New +$298K 0.02% 728
2025
Q2
Sell
-11,246
Closed -$4.89M 897
2025
Q1
$4.89M Buy
11,246
+229
+2% +$91.9K 0.31% 79
2024
Q4
$4.06M Sell
11,017
-893
-7% -$374K 0.26% 94
2024
Q3
$6.19M Buy
11,910
+11,450
+2,489% +$6.12M 0.4% 58
2024
Q2
$249K Sell
460
-26
-5% -$13.7K 0.03% 520
2024
Q1
$252K Buy
486
+1
+0.2% +$497 0.03% 550
2023
Q4
$229K Sell
485
-3
-0.6% -$1.39K 0.03% 540
2023
Q3
$212K Buy
488
+1
+0.2% +$454 0.02% 526
2023
Q2
$216K Buy
487
+7
+1% +$3.23K 0.03% 515
2023
Q1
$221K Buy
480
+19
+4% +$9.04K 0.03% 481
2022
Q4
$236K Sell
461
-2
-0.4% -$1.01K 0.03% 455
2022
Q3
$211K Buy
+463
New +$222K 0.03% 456
2022
Q1
Sell
-444
Closed -$206K 568
2021
Q4
$206K Buy
+444
New +$187K 0.02% 557
2021
Q3
Sell
-550
Closed -$210K 603
2021
Q2
$210K Buy
+550
New +$210K 0.02% 535

Other funds holding ELV

Hilltop Holdings's ELV Position: Q4 2025 in Review

Hilltop Holdings sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 957 shares — an estimated $309K sold.

Hilltop Holdings first reported a position in ELV in Q2 2021 and held it in 14 quarters. The position peaked at $6.19M in Q3 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Hilltop Holdings reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Hilltop Holdings sold 957 Elevance Health shares in Q4 2025, an estimated $309K.
  • Hilltop Holdings first reported a position in Elevance Health in Q2 2021 and held it in 14 quarters.
  • Hilltop Holdings's Elevance Health position peaked at $6.19M in Q3 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Hilltop Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.